Skip to main content
SpringerLink
Log in

Hypocellular myelodysplastic syndromes

Clinical and biological significance

  • Original Article
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The article is concerned with incidence, clinical features, response to therapy, and prognosis of patients with hypocellular myelodysplastic syndromes. Bone marrow (BM) cellularity <30% (or <20% in patients >70 yr) was found in 24 of 236 (10.2%) trephine biopsies. Median age was 61 yr, with significant male predominance (M/F=3.0) At diagnosis, median hemoglobin was 83 g/L, median platelet and neutrofil counts were 31 × 109/L and 1.2 × 109/L, respectively. According to FAB classification, 17 patients had RA, 6 had RAEB, and only 1 had RAEB-t. Beside marrow hypoplasia, the most prominent PH finding was megakaryocyte hypoplasia and dysplasia, found in two-thirds of cases, each. Comparison between hypocellular and normo/hypercellular MDS cases regarding clinicopathological features showed younger age, more severe cytopenia, less blood and BM blast infiltration, MK hypoproliferation, and more pronounced stromal reactions in former cases. Karyotypic abnormalities were present in 12.5% hypocellular cases, in contrast to 44.6% normo/hypercellular cases (p=0.0025). Eleven patients were treated with supportive therapy alone, six with danazol or androgens, six with immunosuppressive therapy, and one with LDARAC. However, complete or partial response was achieved in only four patients treated with danazol or androgens. None of the patients developed leukemia. Eleven patients died, so marrow insufficiency was the main cause of death. Median survival was 33 mo for hypocellular MDS, and 19 mo for normo/hypercellular MDS (p=0.09). The results confirm the existence of hypocellular variant of MDS, which seems to have better prognosis than those patients with normo/hypercellular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Maschek H, et al. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics and prognosis. Ann Haematol 1993; 66: 117–122.

    Article  CAS  Google Scholar 

  2. Riccardi A, et al. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity. Blut 1987; 54: 153–163.

    Article  PubMed  CAS  Google Scholar 

  3. Nand S, Godwin J. Hypoplastic myelodysplastic syndrome. Cancer 1988; 62: 958–964.

    Article  PubMed  CAS  Google Scholar 

  4. Yoshida Y, Oguma H, Maekawa T. Refractory myelodysplastic anaemias with hypocellular bone marrow. J Clin Pathol 1988; 41: 763–767.

    Article  PubMed  CAS  Google Scholar 

  5. Toyama K, et al. Clinical and cytogenetic findings of myelodysplastic syndrome showing hypocellular bone marrow or minimal dysplasia. Int J Haematol 1993; 58: 53–61.

    CAS  Google Scholar 

  6. Bennett J, Catovsky D, Flandrin G, Galton D, Gralnick H, Sultan C. The French-American-British (FAB) cooperative group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199.

    PubMed  CAS  Google Scholar 

  7. Harris NL, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849.

    PubMed  CAS  Google Scholar 

  8. Mungi M, Mufti G. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 1992; 79: 198–205.

    Google Scholar 

  9. Mufti G, Stevens J, Oscier D, Hamblin T, Mechin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985; 59: 425–433.

    Article  PubMed  CAS  Google Scholar 

  10. Sanz GF, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395–408.

    PubMed  CAS  Google Scholar 

  11. Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W. Risk assessment in primary myelodysplastic syndromes: validation of the Dusseldorf score. Leukemia 1994; 8: 1906–1913.

    PubMed  CAS  Google Scholar 

  12. Morel P, et al. Cytogenetic analysis has a strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 7: 1315–1323.

    PubMed  CAS  Google Scholar 

  13. Greenberg P, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.

    PubMed  CAS  Google Scholar 

  14. Maschek H, Gutzmer R, Choritz H, Georgii A. Life expectancy in primary myelodysplastic syndromes (pMDS): a prognostic score based upon histopathology from bone marrow biopsies of 569 patients. Eur J Haematol 1994; 53: 280–287.

    Article  PubMed  CAS  Google Scholar 

  15. ISCN. Mitelman F (ed). An International System for Human Genetic Nomenclature. Karger: Basel, 1995.

    Google Scholar 

  16. Iscove N, Sieber F, Winterhalter K. Erythoroid colony formation in cultures of mouse and human bone marrow: analysis of the requirements of erythropoietin by gel filtration and affinity chromatography on agarose-concavalin A. J Cell Physiol 1974; 83: 309–315.

    Article  PubMed  CAS  Google Scholar 

  17. Raymakers R, Preijers F, Boezeman J, Rutten E, De Witte T. Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysis. Leuk Lymphoma 1993; 14: 111–120.

    Article  Google Scholar 

  18. Hellstrom-Lindberg E, et al. A predictive model for the clinical response to low dose Ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukemia. Br J Haematol 1992; 81: 503–511.

    Article  PubMed  CAS  Google Scholar 

  19. Marisavljević D, Rolović Z, Čemerikić-Martinović V, Bošković D, Čolović M. Hyperfibrotic myelodysplastic syndromes: biological and clinical characteristics. Haema 2004; 7: 479–484.

    Google Scholar 

  20. Rios A, et al. Bone marrow biopsy in myelodisplastic syndromes: morphological characteristics and contribution to the study of prognostic factors. Br J Haematol 1990; 75: 26–33.

    Article  PubMed  CAS  Google Scholar 

  21. Kitigawa M, Kamiyama R, Tekemura T, Kasuga T. Bone marrow analysis of the myelodysplastic syndromes: histological and immun-histological features related to evolution of overt leukemia. Virch Arch (B) 1989; 57: 47–53.

    Article  Google Scholar 

  22. Delacretaz F, Schmidt PM, Piguet D, Bachmann F, Costa J. Histopatology of myelodysplastic syndromes: the FAB classification (proposals) applied to bone marrow biopsy. Am J Clin Pathol 1987; 87: 180–186.

    PubMed  CAS  Google Scholar 

  23. Bartl R, Frisch B, Baumgart R. Morphologic classification of the myelodysplastic syndromes (MDS): combined utilization of bone marrow aspirates and trephine biopsies. Leuk Res 1992; 16: 15–33.

    Article  PubMed  CAS  Google Scholar 

  24. Tuzuner N, Christopher C, Rowe J, Watrous D, Bennett J. Hypocellular myelodysplastic syndromes (MDS): new proposals. Br J Haematol 1995; 91: 612–617.

    Article  PubMed  CAS  Google Scholar 

  25. Fohlmeister I, Fischer R, Schaefer H. Preleukemic myelodysplastic syndromes (MDS): pathogenetic considerations based on retrospective clinicomorphological sequential studies. Anticancer Res 1985; 5: 179–188.

    PubMed  CAS  Google Scholar 

  26. Tuzuner N, Cox C, Rowe J, Bennett J. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction. Leuk Res 1994; 18: 559–564.

    Article  PubMed  CAS  Google Scholar 

  27. Fohlmeister I, Fischer R, Mődder B, Rister M, Schaefer H. Aplastic anemia and hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol 1985; 38: 1218–1224.

    Article  PubMed  CAS  Google Scholar 

  28. De Planque M, et al. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol 1988; 70: 55–62.

    Article  PubMed  Google Scholar 

  29. Tomonaga M, Tomonaga Y, Kusano M, Ichimaru M. Sequential karyotypic evolutions and bone marrow aplasia preceding acute myelomonocytic transformation from myelodysplastic syndrome. Br J Haematol 1984; 58: 53–60.

    Article  PubMed  CAS  Google Scholar 

  30. Pedersen-Bjergaard J. Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia: a review. Leuk Res 1992; 16: 61–64.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Haematology, Clinical Centre of Serbia, Koste Todorovića 2, 11000, Belgrade, Serbia and Montenegro

    Dragomir Marisavljević, Vesna Čemerikić, Zoran Rolović, Darinka Bošković & Milica Čolović

Authors
  1. Dragomir Marisavljević
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vesna Čemerikić
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zoran Rolović
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Darinka Bošković
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Milica Čolović
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dragomir Marisavljević.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marisavljević, D., Čemerikić, V., Rolović, Z. et al. Hypocellular myelodysplastic syndromes. Med Oncol 22, 169–175 (2005). https://doi.org/10.1385/MO:22:2:169

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/MO:22:2:169

Key Words

Search

Navigation